Bangalee, A. et al. 2022. MEDICINE AND THE LAW: Dolutegravir as first-line antiretroviral therapy in South Africa: Beware the one-size-fits-all approach. South African Medical Journal. 112, 10 (Oct. 2022), 787–790. DOI:https://doi.org/10.7196/SAMJ.2022.v112i10.16596.